(Q61628384)
Statements
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy (English)
E Bajetta
A M Bochicchio
V Gebbia
F Bozzetti
R Doci
G Bonfanti